Implications of serum calcitonin gene-related peptide and type I interferon in systemic lupus erythematosus-associated headaches.

Saved in:
Bibliographic Details
Title: Implications of serum calcitonin gene-related peptide and type I interferon in systemic lupus erythematosus-associated headaches.
Authors: Sugimoto S; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Shimojima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Kishida D; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Ichikawa T; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Takamatsu R; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Yajima N; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.; Department of Healthcare Epidemiology, School of Public Health in Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan.; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan., Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Rheumatology, Shimane University Faculty of Medicine, Izumo, Japan., Shimizu T; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan., Kida T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Katsuyama T; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Matsuo Y; Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo, Japan.; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo (Tokyo Medical and Dental University), Tokyo, Japan., Kajiyama H; Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma, Japan., Takatani A; Rheumatic Disease Center, Sasebo Chuo Hospital, Sasebo-shi, Japan.; Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Sekijima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
Source: Lupus [Lupus] 2025 May; Vol. 34 (6), pp. 608-616. Date of Electronic Publication: 2025 Apr 03.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first